You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hematological

Showing 26 - 50 of 4,036
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New

Recruiting
  • Mantle-cell Lymphoma
  • B Cell Chronic Lymphocytic Leukemia
    • Monza, MB, Italy
      Andrea Aroldi
    May 24, 2023

    Mature B-cell Tumors Trial (Nemtabrutinib)

    Not yet recruiting
    • Mature B-cell Neoplasms
    • (no location specified)
    Jan 13, 2023

    Hematological Tumors Trial in Beijing (TQB2825 injection)

    Recruiting
    • Hematological Tumors
    • TQB2825 injection
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Aug 4, 2022

    COVID-19 Infection in Hematological Malignancies Patients Trial in Italy

    Recruiting
    • COVID-19 Infection in Hematological Malignancies Patients
      • Brescia, Italy
      • +5 more
      Oct 25, 2022

      Hematological Malignancy, COVID-19 Trial in Beijing (Anti-COVID-19 Antibody SA55 for Injection)

      Recruiting
      • Hematological Malignancy
      • COVID-19
      • Anti-COVID-19 Antibody SA55 for Injection
      • Beijing, Beijing, China
        Beijing Boren Hospital
      Jan 9, 2023

      Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria
      • Anti-C5 antibody treatment
      • Paris, France
        AP-HP Hôpital Saint Louis
      Apr 24, 2023

      Probability of Optimal Target Attainment of Amikacin in Febrile

      Recruiting
      • Febrile Neutropenia (FN)
      • Data collection: Amikacin concentration
      • Basel, Switzerland
        University Hospital Basel, Division of Internal Medicine
      Jan 18, 2023

      Hematological Malignancies, Thrombocytopenia Trial in Atlanta, Decatur (EACA, Platelet transfusion)

      Terminated
      Has Results
      • Hematological Malignancies
      • Thrombocytopenia
      • EACA
      • Platelet transfusion
      • Atlanta, Georgia
      • +1 more
      Jun 26, 2022

      Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)

      Recruiting
      • Solid Tumor
      • Hematological Malignancy
      • East Melbourne, Victoria, Australia
      • +4 more
      Jan 11, 2023

      Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

      Recruiting
      • Hematological Malignancy
      • Ningbo, Zhejiang, China
        The Affiliated People's Hospital of Ningbo University.
      Aug 18, 2022

      Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )

      Recruiting
      • Hematological Disease
      • Allogeneic Hematopoietic Stem Cell Transplantation
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital, Chinese Acade
      Feb 6, 2023

      Hematological Malignancy Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells)

      Not yet recruiting
      • Hematological Malignancy
      • Fludarabine Phosphate
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Spectrum of Hematological Disorders in Pediatrics

      Not yet recruiting
      • Pancytopenia
      • CBC.with with differential Peripheral smear
      • (no location specified)
      Jul 22, 2022

      Cancer, Sleep Disturbance, Anxiety Trial in San Francisco (Calm Meditation, Health Education Podcast)

      Not yet recruiting
      • Cancer
      • +5 more
      • Calm Meditation
      • Health Education Podcast
      • Phoenix, Arizona
      • +1 more
      Jan 11, 2023

      Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)

      Completed
      Has Results
      • Myeloid Hematological Malignancies
      • Houston, Texas
        Texas Children's Hospital
      May 13, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Feb 22, 2023

      Hematological Malignancies Trial (Anti-CD7 CAR-T)

      Not yet recruiting
      • Hematological Malignancies
      • Anti-CD7 CAR-T
      • (no location specified)
      Jul 8, 2022

      Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Feb 20, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Feb 16, 2023

      Secondary Antibody Deficiency Trial (Immunoglobulin replacement therapy (IGRT))

      Not yet recruiting
      • Secondary Antibody Deficiency
      • Immunoglobulin replacement therapy (IGRT)
      • (no location specified)
      Nov 4, 2022

      Hematological Malignancy, Lymphoma Trial in Canton (SG2501)

      Recruiting
      • Hematological Malignancy
      • Lymphoma
      • Canton, Ohio
        Gabrail Cancer Center Research, LLC
      Aug 3, 2022

      Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

      Recruiting
      • Neoplasms
      • +3 more
      • RD13-02 cell infusion
      • Wuhan, Hubei, China
        Union Hospital, Huazhong University of Science and Technology
      Jun 8, 2023

      Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)

      Active, not recruiting
      • Hematologic Neoplasm
      • Neoplasms
      • Gainesville, Florida
      • +2 more
      Jan 12, 2023

      Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

      Recruiting
      • Hematopoietic Malignancy
      • +2 more
      • Umbilical Cord Blood Transplantation
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow university
      Nov 6, 2023

      Acute Lymphoblastic Leukemia, Lymphoma, Multiple Myeloma Trial in Taiyuan (CAR-T Autologous T cell injection)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • CAR-T Autologous T cell injection
      • Taiyuan, Shanxi, China
        Shanxi Bethune Hospital
      Dec 2, 2022